Author page: Jenna Lambert

Congratulations to Aleks on his Fellowship Award

The Lipshutz Lab would like to congratulate Aleks on his recent fellowship award. This fellowship comes from the Association for Creatine Disorders and it is for his project “Unraveling Cerebral Creatine Deficiency Syndromes: Insights into Neurodevelopment through Organoid Research.” He aims to comprehensively unravel the cellular and molecular intricacies of SLC6A8 and GAMT mutation-related neural impairment while simultaneously explore the…

Read more

Congratulations to Taryn Diep on her Accepted Oral Presentation

The Lipshutz Lab would like to congratulate Staff Research Associate Taryn Diep on her accepted oral presentation. Out of 175 submitted abstracts to the 2024 Society for Inherited Metabolic Disorders (SIMD) Conference, Taryn’s abstract – centered on the dysmyelination of Arginase deficiency, has been selected as one of only six oral presentations. Congratulations on this accomplishment Taryn!

Read more

Lipshutz Lab Presentations at the 26th Annual American Society of Gene and Cell Therapy Conference

Lizzie Zhang and Dr. Gerry Lipshutz presented at this year’s ASGCT Conference. Lizzie presented “Oligodendrocyte Toxicity by Guanidino Compounds, Not Arginine, Fosters Dysmyelination in Arginase Deficiency and is Prevented by AAV-Based Gene Therapy.” Dr. Lipshutz presented “mRNA-3927 Therapy for Propionic Acidemia: Interim Data From a Phase 1/2 Study.” Congratulations to both Lizzie and Dr. Lipshutz!

Read more

Lipshutz Lab receives new CIRM grant to develop stem-cell based therapies for SLC6a8 gene

Dr. Gerald Lipshutz has been awarded the Quest Award by the California Institute for Regenerative Medicine (CIRM)! The $2.3 million award will fund the lab’s work to develop a one-time gene therapy to treat creatine transporter deficiency, which inhibits creatine—a molecule that is an essential energy source for brain and muscle cells—from reaching the brain and muscles and causes neural…

Read more